Poster: ABCL-351: Promising Tolerability and Efficacy Results from Dose-Escalation in an Ongoing Phase Ib/II Study of Mosunetuzumab with Polatuzumab Vedotin (Pola) in Patients with Relapsed/Refractory (R/R) B-Cell Non-Hodgkin Lymphoma (B-NHL)

Elizabeth Budde; Nilanjan Ghosh; Julio Chavez; Izidore S. Lossos; Amitkumar Mehta; Kathleen Dorritie; Manali Kamdar; Raluca Negricea; Song Pham; Maria Hristopoulos; Ling-Yuh Huw; Carol O’Hear; Yasuhiro Oki; Iris To; Catherine Diefenbach

doi:10.1016/S2152-2650(21)01516-0

$Poster: ABCL-351: Promising Tolerability and Efficacy Results from Dose-Escalation in an Ongoing Phase Ib/II Study of Mosunetuzumab with Polatuzumab Vedotin (Pola) in Patients with Relapsed/Refractory (R/R) B-Cell Non-Hodgkin Lymphoma (B-NHL)$

Journal article

Peer reviewed

Poster: ABCL-351: Promising Tolerability and Efficacy Results from Dose-Escalation in an Ongoing Phase Ib/II Study of Mosunetuzumab with Polatuzumab Vedotin (Pola) in Patients with Relapsed/Refractory (R/R) B-Cell Non-Hodgkin Lymphoma (B-NHL)

Elizabeth Budde, Nilanjan Ghosh, Julio Chavez, Izidore S. Lossos, Amitkumar Mehta, Kathleen Dorritie, Manali Kamdar, Raluca Negricea, Song Pham, Maria Hristopoulos, …

Clinical lymphoma, myeloma and leukemia, Vol.21, pp.S241-S241

2021-09

DOI: https://doi.org/10.1016/S2152-2650(21)01516-0

Metrics

3 Record Views

Details

Title: Poster: ABCL-351: Promising Tolerability and Efficacy Results from Dose-Escalation in an Ongoing Phase Ib/II Study of Mosunetuzumab with Polatuzumab Vedotin (Pola) in Patients with Relapsed/Refractory (R/R) B-Cell Non-Hodgkin Lymphoma (B-NHL)
Creators: Elizabeth Budde - City Of Hope National Medical Center
Nilanjan Ghosh - Levine Cancer Institute
Julio Chavez - Moffitt Cancer Center
Izidore S. Lossos - University of Miami Health System
Amitkumar Mehta - University of Alabama at Birmingham
Kathleen Dorritie - UPMC Hillman Cancer Center
Manali Kamdar - University of Colorado Cancer Center
Raluca Negricea - Roche
Song Pham - Roche
Maria Hristopoulos - Genentech
Ling-Yuh Huw - Genentech
Carol O’Hear - Genentech
Yasuhiro Oki - Genentech
Iris To - Genentech
Catherine Diefenbach - NYU Langone Health
Publication Details: Clinical lymphoma, myeloma and leukemia, Vol.21, pp.S241-S241
Publisher: Elsevier Inc
Academic Unit: Miller School of Medicine; UMMG Dept of Medicine - Hematology/Oncology
Language: English
Resource Type: Journal article
Record Identifier: 991031758098402976